PET Imaging of Both Primary and Metastatic Prostate Cance
March 21, 2017 | Terry Sharrer

PET CT
Researchers at the National Institute of Biomedical Imaging and Bioengineering, NIH (Bethesda, MD) have developed a new PET imaging agent that can reveal both primary prostate cancer cells and metastatic ones. As this piece reads: “The new agent is a gallium-68 (Ga-68)-labeled peptide BBN-RGD agent that targets both gastrin-releasing peptide receptor (GRPR) and integrin αvβ3. Dual-receptor targeting provides advantages over single-receptor targeting by allowing tumor contrast when either or both receptor types are expressed, improving binding affinity and increasing the number of effective receptors.” MORE
Image Credit: Wikimedia.commons
Key words: